Your browser doesn't support javascript.
loading
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition.
Li, Bob T; Daly, Bobby; Gospodarowicz, Mary; Bertagnolli, Monica M; Brawley, Otis W; Chabner, Bruce A; Fashoyin-Aje, Lola; de Claro, R Angelo; Franklin, Elizabeth; Mills, Jennifer; Legos, Jeff; Kaucic, Karen; Li, Mark; The, Lydia; Hou, Tina; Wu, Ting-Hui; Albrecht, Bjorn; Shao, Yi; Finnegan, Justin; Qian, Jing; Shahidi, Javad; Gasal, Eduard; Tendler, Craig; Kim, Geoffrey; Yan, James; Morrow, Phuong Khanh; Fuchs, Charles S; Zhang, Lianshan; LaCaze, Robert; Oelrich, Stefan; Murphy, Martin J; Pazdur, Richard; Rudd, Kevin; Wu, Yi-Long.
Afiliación
  • Li BT; Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA. lib1@mskcc.org.
  • Daly B; Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Gospodarowicz M; Princess Margaret Cancer Center, , University of Toronto, Toronto, Ontario, Canada.
  • Bertagnolli MM; Dana-Farber Brigham Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Brawley OW; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Chabner BA; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Fashoyin-Aje L; Society for Translational Oncology, Durham, NC, USA.
  • de Claro RA; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA.
  • Franklin E; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA.
  • Mills J; Cancer Support Community, Washington, DC, USA.
  • Legos J; Foundation Medicine, Inc., Cambridge, MA, USA.
  • Kaucic K; Novartis, Basel, Switzerland.
  • Li M; PPD, Inc., Wilmington, NC, USA.
  • The L; Resolution Bioscience, Agilent Technologies, Kirkland, WA, USA.
  • Hou T; McKinsey Cancer Center, McKinsey & Company.
  • Wu TH; McKinsey Cancer Center, McKinsey & Company.
  • Albrecht B; McKinsey Cancer Center, McKinsey & Company.
  • Shao Y; McKinsey Cancer Center, McKinsey & Company.
  • Finnegan J; McKinsey Cancer Center, McKinsey & Company.
  • Qian J; Bloomberg New Economy, Bloomberg L.P., New York, NY, USA.
  • Shahidi J; Asia Society Policy Institute, Asia Society, New York, NY, USA.
  • Gasal E; Daiichi Sankyo, Tokyo, Japan.
  • Tendler C; Innovent Biologics, Suzhou, China.
  • Kim G; Janssen, Johnson and Johnson, New Brunswick, NJ, USA.
  • Yan J; BeiGene USA, BeiGene, Beijing, China.
  • Morrow PK; Zai Lab, Shanghai, China.
  • Fuchs CS; Amgen, Inc, Thousand Oaks, CA, USA.
  • Zhang L; Genentech, South San Francisco, CA, USA.
  • LaCaze R; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
  • Oelrich S; Jiangsu Hengrui Pharmaceuticals, Shanghai, China.
  • Murphy MJ; Bayer AG, Leverkusen, Germany.
  • Pazdur R; Bayer AG, Leverkusen, Germany.
  • Rudd K; Society for Translational Oncology, Durham, NC, USA.
  • Wu YL; Shanghai TuoXin Health Promotion Center, Shanghai, China.
Nat Med ; 28(4): 620-626, 2022 04.
Article en En | MEDLINE | ID: mdl-35440725
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos